Pharmacoeconomic simulation of delayed results of the treatment of type 2 diabetes mellitus with modern insulin analogsin comparison with oral hypoglycemic agents
Aim. To carry out cost-effectiveness analysis of treatment options for type 2 diabetes using different groups of medicines, to prognosticate late diabeticcomplications and the cost of their management. Materials and methods. A total of 3678 DM2 patients (with mean HbAc1 level 9.3%) were examined i...
Guardado en:
Autores principales: | Ivan Ivanovich Dedov, Marina Vladimirovna Shestakova, Yury Ivanovich Suntsov, Roza Imailovna Yagudina, Ivan Sergeevich Krysanov, Andrey Yur'evich Kulikov, Evgenia Evgen'evna Arinina |
---|---|
Formato: | article |
Lenguaje: | EN RU |
Publicado: |
Endocrinology Research Centre
2010
|
Materias: | |
Acceso en línea: | https://doaj.org/article/6244d694f989443796f5619c483ff780 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Pharmacoeconomic analysis of conservative strategy for the treatment of patients with diabetic foot syndrome in Moscow
por: Marina Fedorovna Kalashnikova, et al.
Publicado: (2011) -
Pharmacoeconomic effectiveness of phytotherapy in complex treatment of pyelonephritis
por: V. V. Ivanov, et al.
Publicado: (2015) -
Current Trends and Challenges in Pharmacoeconomic Aspects of Nanocarriers as Drug Delivery Systems for Cancer Treatment
por: Milewska S, et al.
Publicado: (2021) -
PHARMACOECONOMICS OF APPLICATION OF HEPATOPROTECTORS IN THERAPY OF DRUG-INDUCED LIVER INJURY AFTER CHEMOTHERAPY
por: D. D. Morikov, et al.
Publicado: (2017) -
Pharmacoepidemiological and pharmacoeconomic analyses of the utilization of hypoglycaemic drugs in patients with type 2 diabetes mellitus in Moscow
por: Marina Fedorovna Kalashnikova, et al.
Publicado: (2015)